Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Hires PDI to Launch and Sell Prenatal Test

NEW YORK (GenomeWeb News) – Sequenom today said that it has inked a contract with sales and marketing services firm PDI to provide the sales force that will launch and commercialize the firm's SEQureDx non-invasive prenatal genetic screening tests.

PDI will work with the Sequenom Center for Molecular Medicine, the clinical lab subsidiary of Sequenom, in supporting commercialization of the firm's Rhesus D genotyping test, its Down syndrome test, and other laboratory-developed tests. The partners will hire, train, and develop a sales team for the SCMM.

The contract follows comments made last month by Sequenom President and CEO Harry Stylli that the firm would work with a contract sales force organization and target a sales force of 150 to 175 reps focused on the obstetrics/gynecology market in the US for its SEQureDx Down Syndrome test, which is scheduled for a June launch.

Sequenom said today that the firm plans to hire an initial wave of business development managers in the first quarter of this year followed by an expansion throughout the remainder of 2009.

Financial terms of the contract were not disclosed.

"As we grow the market for SEQureDx tests, PDI's flexible approach allows them to be responsive to our needs with minimal advance notice, so we can most efficiently and effectively build our sales organization," Stylli said in a statement.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.